Device enhancement or recall? US FDA clarifies further
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has sought to further clarify guidelines it issued on 15 October on whether manufacturers who make changes to a medical device that is already on the market in US are enhancing it or actually effecting a recall1-3.